BiotechTube

Amifostine

ApprovedWithdrawn
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Oral Mucositis

Conditions

Oral Mucositis, Stomatitis

Trial Timeline

— → —

NCT ID
NCT01288625

About Amifostine

Amifostine is a approved stage product being developed by Sun Pharmaceutical for Oral Mucositis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01288625. Target conditions include Oral Mucositis, Stomatitis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01288625ApprovedWithdrawn

Competing Products

20 competing products in Oral Mucositis

See all competitors
ProductCompanyStageHype Score
AL001 + Placebo + Open label - AL001AlectorPhase 3
69
AL001AlectorPhase 2
44
AG013OragenicsPhase 2
44
LP-10 (Liposomal Tacrolimus)Lipella PharmaceuticalsPhase 2
44
Micafungin + FluconazoleAstellas PharmaPhase 3
77
micafungin + caspofunginAstellas PharmaPhase 3
77
Erlotinib + PlaceboAstellas PharmaPhase 3
77
exenatide + Other antidiabetic therapiesEli LillyPre-clinical
23
Teriparatide 20 mcgEli LillyPhase 3
77
LY3884963 + Methylprednisolone + Optional Sirolimus + Optional PrednisoneEli LillyPhase 1/2
41
Baricitinib 4 milligram Oral TabletEli LillyPhase 2
52
tramadol hydrochloride + acetaminophenJohnson & JohnsonApproved
85
Essential oils + 0.2% chlorhexidine + Sterile waterJohnson & JohnsonApproved
85
galantamine hydrobromideJohnson & JohnsonPhase 2
52
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77
Camrelizumab + Camrelizumanb plus TPFJiangsu Hengrui MedicinePhase 2
52
Camrelizumab plus TP + TPJiangsu Hengrui MedicinePhase 3
77
AZD1981 + Neovletta 21/28 + Placebo AZD1981AstraZenecaPhase 1
33
DurvalumabAstraZenecaPhase 1/2
41
fostamatinib + Microgynon® 30 (Oral contraceptive) + PlaceboAstraZenecaPhase 1
33

Other Products from Sun Pharmaceutical

Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85
Sonidegib Phosphate CapsulesApproved
85